Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study

Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E...

Full description

Saved in:
Bibliographic Details
Main Authors: Tyler S. Bryant, Priya Duggal, Bing Yu, Alanna C. Morrison, Tariq Shafi, Georg Ehret, Nora Franceschini, Eric Boerwinkle, Josef Coresh, Adrienne Tin
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2019/2137629
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558929823924224
author Tyler S. Bryant
Priya Duggal
Bing Yu
Alanna C. Morrison
Tariq Shafi
Georg Ehret
Nora Franceschini
Eric Boerwinkle
Josef Coresh
Adrienne Tin
author_facet Tyler S. Bryant
Priya Duggal
Bing Yu
Alanna C. Morrison
Tariq Shafi
Georg Ehret
Nora Franceschini
Eric Boerwinkle
Josef Coresh
Adrienne Tin
author_sort Tyler S. Bryant
collection DOAJ
description Flavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5%) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1%, p=0.0003) and European Americans (rs75904274, MAF 1.7%, p=0.006). These associations were not significant with additional samples: E158K in a meta-analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.
format Article
id doaj-art-508061a1c38349c581446ab1a9670f68
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-508061a1c38349c581446ab1a9670f682025-02-03T01:31:16ZengWileyInternational Journal of Hypertension2090-03842090-03922019-01-01201910.1155/2019/21376292137629Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities StudyTyler S. Bryant0Priya Duggal1Bing Yu2Alanna C. Morrison3Tariq Shafi4Georg Ehret5Nora Franceschini6Eric Boerwinkle7Josef Coresh8Adrienne Tin9Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USADepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAHuman Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USAHuman Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USADivision of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USACenter for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USAGillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USAHuman Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USADepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USADepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD, USAFlavin containing monooxygenase 3 [FMO3] encodes dimethylaniline monooxygenase [N-oxide-forming] 3, which breaks down nitrogen-containing compounds, and has been implicated in blood pressure regulation. Studies have reported conflicting results of the association of a common nonsynonymous variant, E158K (rs2266782), with hypertension. We examined the associations of E158K, along with rare and low frequency exonic variants (minor allele frequency [MAF]<5%) in FMO3 with hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP). We included 7,350 European Americans and 2,814 African Americans in the Atherosclerosis Risk in Communities (ARIC) study with exome sequencing of FMO3. The association of FMO3 variants with SBP and DBP was tested using single variant and gene-based tests followed by the replication or interrogation of significant variants in ancestry-specific cohorts based on Bonferroni corrected thresholds. E158K had significant association with higher SBP in African Americans in ARIC (p=0.03), and two low frequency variants had significant association with higher SBP in African Americans (rs200985584, MAF 0.1%, p=0.0003) and European Americans (rs75904274, MAF 1.7%, p=0.006). These associations were not significant with additional samples: E158K in a meta-analysis of SBP of African ancestry (N=30,841, p=0.43) that included ARIC participants and the two low frequency variants in an independent ancestry-specific exome sequencing study of blood pressure (rs200985584, p=0.94; rs75904274, p=0.81). Our study does not support the association of E158K and low frequency variants in FMO3 with blood pressure and demonstrates the importance of replication in genetic studies.http://dx.doi.org/10.1155/2019/2137629
spellingShingle Tyler S. Bryant
Priya Duggal
Bing Yu
Alanna C. Morrison
Tariq Shafi
Georg Ehret
Nora Franceschini
Eric Boerwinkle
Josef Coresh
Adrienne Tin
Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
International Journal of Hypertension
title Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
title_full Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
title_fullStr Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
title_full_unstemmed Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
title_short Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
title_sort association of fmo3 variants with blood pressure in the atherosclerosis risk in communities study
url http://dx.doi.org/10.1155/2019/2137629
work_keys_str_mv AT tylersbryant associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT priyaduggal associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT bingyu associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT alannacmorrison associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT tariqshafi associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT georgehret associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT norafranceschini associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT ericboerwinkle associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT josefcoresh associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy
AT adriennetin associationoffmo3variantswithbloodpressureintheatherosclerosisriskincommunitiesstudy